Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Transcatheter Mitral Valve Repair or Replacement : Competitive or Complementary? / Xiling, Zhang; Puehler, Thomas; Sondergaard, Lars; Frank, Derk; Seoudy, Hatim; Mohammad, Baland; Müller, Oliver J.; Sellers, Stephanie; Meier, David; Sathananthan, Janarthanan; Lutter, Georg.
I: Journal of Clinical Medicine, Bind 11, Nr. 12, 3377, 2022.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Transcatheter Mitral Valve Repair or Replacement
T2 - Competitive or Complementary?
AU - Xiling, Zhang
AU - Puehler, Thomas
AU - Sondergaard, Lars
AU - Frank, Derk
AU - Seoudy, Hatim
AU - Mohammad, Baland
AU - Müller, Oliver J.
AU - Sellers, Stephanie
AU - Meier, David
AU - Sathananthan, Janarthanan
AU - Lutter, Georg
N1 - Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022
Y1 - 2022
N2 - Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.
AB - Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.
KW - access
KW - approach
KW - endovascular
KW - mitral insufficiency
KW - mitral regurgitation
KW - percutaneous
KW - transcatheter mitral valve repair
KW - transcatheter mitral valve replacement
KW - transcatheter technology
KW - transluminal
U2 - 10.3390/jcm11123377
DO - 10.3390/jcm11123377
M3 - Review
C2 - 35743448
AN - SCOPUS:85132071448
VL - 11
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
SN - 2077-0383
IS - 12
M1 - 3377
ER -
ID: 321959705